Can HPV vaccination help to prevent anal cancer?

The Lancet Infectious Diseases

Volumn 10, Issue 12, 2010, Pages 815-816

  Palefsky, Joel ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

ANUS CANCER; CANCER INCIDENCE; CANCER RISK; CARCINOMA IN SITU; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; FOOD AND DRUG ADMINISTRATION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 6; LETTER; MALE; MALE HOMOSEXUAL; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA IN SITU; VACCINATION; WART VIRUS;

ANUS NEOPLASMS; COST-BENEFIT ANALYSIS; HOMOSEXUALITY, MALE; HUMANS; IMMUNIZATION; MALE; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES;

EID: 78649445367     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(10)70226-7     Document Type: Letter

References (13)

1. Kim JJ Targeted human papillomavirus vaccination of men who have sex with men in the USA: a cost-effectiveness modelling analysis. Lancet 2010, published online Nov 3. DOI:S1473-3099(10)70219-X.
2. Seaberg EC, Wiley D, Martinez-Maza O, et al. Cancer incidence in the multicenter aids cohort study before and during the HAART era: 1984 to 2007. Cancer 2010, published online July 29. 10.1002/cncr.25530.
3. Daling JR, Weiss NS, Hislop TG, et al. Sexual practices, sexually transmitted diseases, and the incidence of anal cancer. N Engl J Med 1987, 317:973-977.
4. Frisch M, Biggar RJ, Goedert JJ Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst 2000, 92:1500-1510.
5. Joseph DA, Miller JW, Wu X, et al. Understanding the burden of human papillomavirus-associated anal cancers in the US. Cancer 2008, 113(suppl):2892-2900.
6. Schiller JT, Lowy DR Vaccines to prevent infections by oncoviruses. Annu Rev Microbiol 2010, 64:23-41.
7. National, state, and local area vaccination coverage among adolescents aged 13-17 years-United States, 2008. MMWR Morb Mortal Wkly Rep 2009, 58:997-1001. Centers for Disease Control and Prevention.
8. Palefsky J, Giuliano AR The efficacy of quadrivalent HPV (types 6/11/16/18) vaccine in reducing the incidence of HPV-related genital disease in young men (accessed Oct 27, 2010). http://www.eurogin.com/2008/EUROGIN2008_LastMinuteAbstracts.pdf.
9. FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2010, 59:630-632. US Centers for Disease Control and Prevention.
10. Palefsky J. Efficacy of the quadrivalent HPV vaccine to prevent anal intraepithelial neoplasia among young men who have sex with men. 26th International Papillomavirus Conference; Montreal, Canada; July 3-8, 2010.
11. Palefsky JM Anal cancer prevention in HIV-positive men and women. Curr Opin Oncol 2009, 21:433-438.
12. Simatherai D, Bradshaw CS, Fairley CK, Bush M, Heley S, Chen MY What men who have sex with men think about the human papillomavirus vaccine. Sex Transm Infect 2009, 85:148-149.
13. Elbasha EH, Dasbach EJ Impact of vaccinating boys and men against HPV in the United States. Vaccine 2010, 28:6858-6867.